Innovating organ-on-chip to accelerate research

Portuguese start-up BIOFABICS has received funding from the European Union’s Horison 2020 research and innovation programme to explore organ-on-chip

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

BIOFABICS brings custom design tools to biofabrication.

While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity sector, and is predicted to become a $100 million market by 2025 [1]. Key to the success of OOCs are the biotissues and technologies needed to develop them.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE